Invasive candidiasis: turning risk into a practical prevention policy?
Sobel
J D
JD
Rex
J H
JH
D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002175:Candida / Q000187:drug effects / Q000254:growth & development; D002177:Candidiasis / Q000097:blood / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*; D003422:Critical Care; D016469:Fungemia / Q000097:blood / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*; D006801:Humans; D007362:Intensive Care Units; D009894:Opportunistic Infections / Q000097:blood / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D000935:Antifungal Agents